The Duchenne Muscular Dystrophy Market is entering a transformative decade marked by rapid scientific innovation, expanding therapeutic pipelines, and increased global awareness. Valued at US$ 2.2 billion in 2023, the market is projected to grow at a compound annual growth rate (CAGR) of 11.7% between 2024 and 2034, reaching approximately US$ 7.4 billion by the end of the forecast period. This...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek